Hi [[ session.user.profile.firstName ]]
Sort by:
    • Understanding Cell Culture Media Composition to Improve Outcomes Understanding Cell Culture Media Composition to Improve Outcomes Brian Posey Upcoming: Jul 28 2016 4:00 pm UTC 60 mins
    • Cell culture media is required for successful and reproducible research but the catalog is full of acronyms and various formulation tables. Classical mammalian cell culture media formulations are very diverse both in terms of the number available and the concentration of constituents. Additionally, each medium was designed for specific cell types and culturing conditions.

      This webinar will cover:
      •The composition, characteristics, environmental factors, and additional supplements required to create optimal conditions for growth and productivity.
      •Determining the right formulation for your application.
      •Serum usage and helpful tips for optimizing your culture conditions.

      Speaker Bio:
      Brian Posey is a Product Development Manager for cell culture media at Corning Life Sciences. Brian has over 10 years experience in cell biology and industrial scale cGMP manufacturing of both liquid and powder cell culture media. Since joining Corning in 2012, Brian has led numerous innovative technology projects for the media business ranging from customer technology transfer for production scale-up to developing new serum-free media for industrial and stem cell lines.

      Read more >
    • The New Age of Regenerative Medicine – Why Stem Cell Therapy? The New Age of Regenerative Medicine – Why Stem Cell Therapy? Jane Andrews, Ph.D., senior consultant, Healthcare & Life Science Recorded: Sep 22 2015 3:00 pm UTC 47 mins
    • Cell therapy is the fastest growing segment of regenerative medicine. Cell therapy is comprised of immune cell therapy and stem cell therapy, with stem cell therapy making up the largest part of this market; it is estimated that the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030.

      Many factors determine the rate at which the stem cell therapy market advances. It is driven by the success of stem cell treatments in curing life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the world’s aging populations. In contrast, the stem cell market growth rate is hindered by manufacturing and regulatory concerns. For example, if only 20% of the 318 global late-stage clinical trials are approved for release on the market, there will not be enough stem cell therapy manufacturing facilities to produce the 64 resulting products. This is due, in part, to funding concerns, the high cost of build-out, as well as cGMP compliance, standardization of production processes, and ever changing industry regulations.

      Read more >
    • The New Age of Regenerative Medicine – Why Stem Cell Therapy? The New Age of Regenerative Medicine – Why Stem Cell Therapy? Jane Andrews, Ph.D ; Sanjeev Kumar ; Rhenu Bhuller Recorded: Jul 28 2015 1:00 am UTC 59 mins
    • Cell therapy is the fastest growing segment of regenerative medicine. Cell therapy is comprised of immune cell therapy and stem cell therapy, with stem cell therapy making up the largest part of this market: it is estimated that the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030.

      Many factors determine the rate at which the stem cell therapy market advances. It is driven by the success of stem cell treatments in curing life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the worlds aging populations. In contrast, stem cell market growth rate is hindered by manufacturing and regulatory concerns. For example, if only 20% of the 318 global late stage clinical trials are approved for release on the market, there will not be enough stem cell therapy manufacturing facilities to produce the 64 resulting products. This is due, in part, to funding concerns, the high cost of build-out as well as cGMP compliance, standardization of production processes, and ever changing industry regulations.

      Join us as we discuss these and other key topics.

      Read more >
    • Tips and Techniques for Serum-free Expansion of hMSCs Tips and Techniques for Serum-free Expansion of hMSCs Brian Posey Recorded: Mar 26 2015 4:00 pm UTC 53 mins
    • Abstract:
      There is a great interest in application of human mesenchymal stem cells (hMSCs) in cell therapy and tissue engineering due to their self-renewal, multi-lineage differentiation, immunomodulation, and trophic potential. One of the challenges faced in the clinical application of hMSCs is the need for efficient expansion of these cells in vitro without altering their capacity. Serum-free mammalian cell culture media, in particular, require optimization of the expansion protocols. Even subtle changes in routine handling can have a significant impact on the cells’ potential.

      This seminar will cover the variables that can influence the desired regenerative and differentiation properties including medium selection, vessel surface treatment, impact of the cell source, and seeding density. We will also discuss how users can select the correct conditions for optimized growth and functionality.

      Speaker Biography:
      Brian Posey is a Product Development Manager for cell culture media at Corning Life Sciences. Brian has over 10 years experience in cell biology and industrial scale cGMP manufacturing of both liquid and powder cell culture media. Since joining Corning in 2012, Brian has lead numerous innovative technology projects for the media business ranging from customer technology transfer for production scale-up to developing new serum-free media for industrial and stem cell lines.

      Read more >